Abstract:Background G Protein Coupled Receptors and regulators of G-protein signalling (RGS), play a pivotal role in the signalling processes associated with atherosclerosis [1]. RGS5 is highly expressed in aortic tissue [2]. Development of atherosclerotic plaque is a complex process that involves foam cells originating from macrophages (Mφ) and/or vascular smooth muscle cells (VSMCs). Differentiation of Mφ and VSMC into various intermediary cells of varying inflammatory potency affects atherosclerotic plaque composition and vulnerability [3]. We hypothesize that RGS5 is involved in signalling of foam cell transition and thus, plaque biology. Purpose To evaluate the role of RGS5 on atherosclerotic plaque complexity and shifts of foam cell origin. Methods ApoE-/-RGS5+/+ and ApoE-/-RGS5-/- mice were fed a high fat Western Diet for 14 weeks. Cryosections bearing aortic valve cusps were used for staining. Lesion size was quantified on hematoxylin and eosin staining. Plaque composition was assessed by CD68, CD45, Oil red O and collagen staining. Triple staining was performed for CD45, CD68 and aSMA. Double immunofluorescent staining for CD45 and pro- and anti-inflammatory markers was carried out. Co-Localisation was analysed by Zeiss Zen. Data were analysed using Mann-Whitney-U test. Results Lesion size was significantly reduced in RGS5-deficient mice in comparison to control (in mm2: 0.398±0.02 vs 0.191±0.09, p=0.0001, n=15). Relative areas positive for Oil Red O and collagen did not differ between genotypes. Area positive for leukocyte marker CD45 increased significantly by 30.8% (p<0.0001, n=15), whereas area positive for CD68 was reduced by 10.3% (p=0.0292, n=15) in RGS5-deficient mice. Absence of RGS5 decreased co-localization of Mφ-derived foam cells by 23% (p=0.03734, n=4-5) while leading to an 5.8% increase in aSMA-derived foam cells compared to control. Area positive for pro-inflammatory M1 Mφ marker CD86 and iNOS increased by 36.3% and 36.8% after RGS5 knock-out (p<0.0001, n=15). No difference in M2 Mφ positive area was observed when RGS5 was lacking. Conclusion RGS5 promotes plaque formation. The number of Mφ-derived foam cells is increased by RGS5, while it reduces inflammatory M1 Mφ. Interestingly, there were no differences in numbers of M2 Mφ, indicating RGS5 inhibits VSMCs transition to M1 Mφ resulting in an overall decrease of CD68-positive foam cells. Further study is required to determine molecular signalling of RGS5 that modulates the phenotype of Mφ- and VSMC-derived cells. RGS5 could be useful as therapeutic target to suppress undesirable plaque phenotypes and to reduce acute cardiovascular events.

RGS5 Attenuates Baseline Activity of ERK1/2 and Promotes Growth Arrest of Vascular Smooth Muscle Cells

Regulator of G Protein Signaling 5 Protects Against Cardiac Hypertrophy and Fibrosis During Biomechanical Stress of Pressure Overload

A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease

Impaired Regulator of G Protein Signaling 2 Transcription Facilitates Vascular Remodeling in Injured Rat Aorta

Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice.

Regulator of G Protein Signalling 14 Attenuates Cardiac Remodelling Through the MEK–ERK1/2 Signalling Pathway

RGS2 is a Primary Terminator of Β2-Adrenergic Receptor-Mediated Gi Signaling

RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment

RGS5, a Hypoxia-inducible Apoptotic Stimulator in Endothelial Cells

Β Adrenergic Receptor-Mediated Atrial Specific Up-Regulation of RGS5

GRK2 expression and catalytic activity are essential for vasoconstrictor/ERK-stimulated arterial smooth muscle proliferation

RGS5 balances macrophage vs vascular smooth muscle cell origin of foam cells in apoE-deficient plaques

Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.

Regulator of G-protein signalling 5 deficiency impairs ventricular remodelling after myocardial infarction by promoting NF-κB and MAPK signalling in mice.

Procontractile G Protein–mediated Signaling Pathways Antagonistically Regulate Smooth Muscle Differentiation in Vascular Remodeling

Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias and disrupts the fine-tuning of Gi/o signaling

Abstract 3142: Pik3c3 Safeguards Smooth Muscle Identity by Promoting Lysosome-mediated Yap1 Degradation

Deregulation of RGS 2 in cardiovascular diseases

Potential Role Of Regulator Of G-Protein Signaling 5 In The Protection Of Vagal-Related Bradycardia And Atrial Tachyarrhythmia

Deregulation of RGS2 in cardiovascular diseases.

CGRP inhibits vascular smooth muscle cell proliferation through suppressing ERK 1 / 2 signaling pathway